scPharmaceuticals Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ORBIMED ADVISORS LLC | 02/14/2025 | 6.06 M | $21.45 M | 0.00% | 13.01% |
RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 4.78 M | $16.90 M | 0.00% | 10.26% |
AIGH CAPITAL MANAGEMENT LLC | 02/12/2025 | 4.17 M | $14.78 M | 1.21% | 8.97% |
KING LUTHER CAPITAL MANAGEMENT CORP | 02/07/2025 | 2.86 M | $10.12 M | 28.40% | 6.14% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.28 M | $8.08 M | 23.17% | 4.90% |
VANGUARD GROUP INC | 02/11/2025 | 2.11 M | $7.46 M | 23.38% | 4.53% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.84 M | $6.52 M | -10.16% | 3.95% |
J. GOLDMAN & CO LP | 02/14/2025 | 1.22 M | $4.32 M | -11.66% | 2.62% |
5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 1.20 M | $4.25 M | 0.00% | 2.58% |
UBS GROUP AG | 02/14/2025 | 1.04 M | $3.67 M | 5,218.29% | 2.23% |
THRIVENT FINANCIAL FOR LUTHERANS | 02/10/2025 | 1.04 M | $3.67 M | -1.17% | 2.23% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.00 M | $3.54 M | 33.33% | 2.15% |
RICE HALL JAMES & ASSOCIATES, LLC | 01/31/2025 | 989,635 | $3.50 M | 59.19% | 2.13% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 02/14/2025 | 800,000 | $2.83 M | 0.00% | 1.72% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 750,493 | $2.66 M | 16.66% | 1.61% |
STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 683,530 | $2.42 M | -12.24% | 1.47% |
TEJARA CAPITAL LTD | 02/10/2025 | 612,850 | $2.17 M | -5.75% | 1.32% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 500,000 | $1.77 M | 100.00% | 1.07% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 409,460 | $1.45 M | 447.63% | 0.88% |
APIS CAPITAL ADVISORS, LLC | 02/14/2025 | 394,000 | $1.39 M | 146.25% | 0.85% |
WOODLINE PARTNERS LP | 02/14/2025 | 297,800 | $1.05 M | -40.63% | 0.64% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 109,909 | $389,078 | -22.13% | 0.24% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 102,854 | $364,103 | 35.53% | 0.22% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 102,300 | $362,142 | -26.88% | 0.22% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 100,400 | $355,416 | 12.05% | 0.22% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 90,503 | $320,381 | -49.62% | 0.19% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 89,690 | $317,503 | 100.00% | 0.19% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 85,900 | $304,086 | 1,393.13% | 0.18% |
JOHNSON FINANCIAL GROUP, LLC | 02/04/2025 | 85,184 | $301,551 | 100.00% | 0.18% |
JPMORGAN CHASE & CO | 02/12/2025 | 84,827 | $300,287 | 587.30% | 0.18% |
DEUTSCHE BANK AG\ | 02/14/2025 | 82,488 | $292,007 | 514.48% | 0.18% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 77,108 | $272,962 | 21.03% | 0.17% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 75,174 | $266,116 | 8.75% | 0.16% |
BALANCED ROCK INVESTMENT ADVISOR | 02/13/2025 | 70,362 | $249,081 | 8.67% | 0.15% |
BARCLAYS PLC | 02/13/2025 | 65,361 | $232,000 | 60.81% | 0.14% |
RHUMBLINE ADVISERS | 01/30/2025 | 42,554 | $150,630 | 20.07% | 0.09% |
CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 40,062 | $141,819 | 116.10% | 0.09% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 38,771 | $137,000 | 0.00% | 0.08% |
THOMASVILLE NATIONAL BANK | 01/13/2025 | 37,500 | $132,750 | 0.00% | 0.08% |
JANE STREET GROUP, LLC | 02/14/2025 | 33,009 | $116,852 | 40.55% | 0.07% |
CITIGROUP INC | 02/12/2025 | 32,513 | $115,097 | 14.41% | 0.07% |
INVESCO LTD. | 02/13/2025 | 27,614 | $97,754 | 28.19% | 0.06% |
XTX TOPCO LTD | 02/13/2025 | 27,531 | $97,460 | 1.33% | 0.06% |
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 02/12/2025 | 23,471 | $84,261 | 31.58% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 21,973 | $77,784 | 36.09% | 0.05% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 21,266 | $75,282 | 13.32% | 0.05% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 19,586 | $69,334 | 29.03% | 0.04% |
03/12/2025 | 19,380 | $68,605 | 100.00% | 0.04% | |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 18,407 | $65,161 | 110.51% | 0.04% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 15,210 | $53,843 | 0.00% | 0.03% |
scPharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 106 institutional investors and hedge funds held shares of scPharmaceuticals Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 6.06 M
Rubric Capital Management LP: 4.78 M
AIGH Capital Management LLC: 4.17 M
KING LUTHER CAPITAL MANAGEMENT CORP: 2.86 M
BlackRock Funding, Inc. /DE: 2.28 M
VANGUARD GROUP INC: 2.11 M
85.39% of scPharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 39.71 M shares in the last 24 months. This purchase volume represents approximately $143.75 M in transactions.